Hermetica Superfood Encyclopedia
The Short Answer
Schinus molle essential oil is dominated by monoterpenes—α-phellandrene (34–47%), β-myrcene (8–24%), and limonene (14%)—which exhibit high nucleophilic reactivity linked to antioxidant, antimicrobial, and antiproliferative mechanisms. In vitro studies demonstrate antibacterial activity against Bacillus cereus at an MIC of 2 µg/mL and inhibition of MCF7 breast cancer cell proliferation at 16–64 µg/mL, though no human clinical trials have yet validated these effects.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordSchinus molle benefits
Peruvian Pepper Tree — botanical close-up
Health Benefits
**Antimicrobial Activity**
The essential oil fraction rich in α-phellandrene and β-myrcene demonstrates minimum inhibitory concentrations as low as 2 µg/mL against Bacillus cereus and 32.5 µg/mL against Yersinia enterocolitica and Salmonella species, suggesting meaningful antibacterial potential relevant to food safety and wound management.
**Antioxidant Defense**
Root aqueous extracts exhibit DPPH radical scavenging with an IC50 of 54.41 µg/mL and FRAP values at IC50 207.42 µg/mL, activities attributed to high concentrations of gallic acid, quinic acid (1,288 µg/g), and condensed tannins (114.83 mg CE/g DW).
**Anti-inflammatory Potential**
Phenolic compounds including quercetin 3-O-glucuronide (up to 564.3 mg/kg in husks) and kaempferol (19 µg/g in roots) are established inhibitors of pro-inflammatory cyclooxygenase and lipoxygenase pathways, providing a mechanistic rationale for traditional use in fever and wound treatment.
**Antiproliferative Effects**
Schinus molle essential oil (SM_EO) increases BCL-2 expression in MCF7 breast cancer cells in a dose-dependent manner at concentrations of 16–64 µg/mL in vitro, indicating modulation of apoptotic pathways, though clinical relevance remains unconfirmed.
**Wound Healing Support**
Traditional topical application of berry decoctions and leaf poultices is supported mechanistically by the combined astringent action of gallotannins such as β-glucogallin (76–443.6 mg/kg) and the antimicrobial monoterpene fraction, which may reduce microbial colonization at wound sites.
**Antipyretic and Antiviral Traditional Use**
Ethnobotanical records across African and South American communities document use of bark and leaf decoctions to reduce fever and manage influenza symptoms, consistent with the anti-inflammatory profile of its flavonoid and phenolic acid constituents, though controlled evidence is absent.
**Low-Toxicity Safety Profile**
Toxicity studies in the Caenorhabditis elegans model at SM_EO concentrations of 0.078–10 mg/mL revealed no significant lethality, and ADME-Tox computational analyses of seed oil monoterpenes classify phellandrenes as favorable drug candidates, supporting a preliminary safety basis for further development.
Origin & History
Natural habitat
Schinus molle is native to the Andean regions of South America, particularly Peru, Bolivia, and Chile, where it thrives in semi-arid, high-altitude environments between 1,500 and 3,500 meters. It has been widely naturalized across Africa, the Mediterranean, the Middle East, and parts of Asia due to its drought tolerance and ornamental value. The tree is cultivated informally along roadsides and in home gardens across sub-Saharan Africa, where it has been adopted into local ethnobotanical traditions for medicinal and culinary purposes.
“Schinus molle has been revered in Andean civilizations for millennia; the Inca used it as a sacred tree, employing its resin, bark, and berries for wound treatment, dental hygiene, and ritualistic purposes, with the fermented berry beverage 'chicha de molle' serving ceremonial roles. Following Spanish colonization, the tree was introduced to Africa, the Mediterranean, and Asia, where it was rapidly adopted into local healing traditions; in sub-Saharan Africa, bark infusions and leaf poultices are used to treat fever, influenza, rheumatism, and infected wounds. In traditional North African and Middle Eastern herbalism, the dried berries function as a spice and carminative, while the essential oil has been applied topically as an antiseptic and insect repellent. Early European botanical records from the 16th century document the tree's medicinal reputation, and it appears in numerous colonial-era pharmacopoeias as a source of balsamic resin with wound-healing and anti-inflammatory properties.”Traditional Medicine
Scientific Research
The current evidence base for Schinus molle consists exclusively of in vitro and invertebrate model studies, with no published human clinical trials reporting sample sizes, randomization, or effect sizes. Key in vitro findings include antibacterial MICs of 2 µg/mL (B. cereus) and 32.5 µg/mL (Salmonella species), antioxidant IC50 of 54.41 µg/mL via DPPH assay from root extracts, and MCF7 cell proliferation inhibition at 16–64 µg/mL essential oil. Toxicological data in Caenorhabditis elegans at 0.078–10 mg/mL SM_EO provides preliminary low-toxicity signals, and computational ADME-Tox analyses suggest favorable pharmacokinetic profiles for phellandrene-class monoterpenes. The overall evidence quality is low by clinical standards; findings are hypothesis-generating and require validation in animal models and subsequently randomized controlled trials before any therapeutic claims can be substantiated.
Preparation & Dosage
Traditional preparation
**Essential Oil (Seed/Berry)**
Used experimentally at 2–32.5 µg/mL for antimicrobial testing; no established human supplemental dose. Extracted by hydrodistillation and characterized by GC-MS; α-phellandrene content varies 34–47% by berry maturity.
**Aqueous Root Extract**
10–30 g dried root per liter of water
Prepared by decoction or cold maceration; antioxidant activity observed at IC50 54.41 µg/mL in vitro. No standardized human dose has been established; traditional preparations use approximately .
**Berry Decoction (Traditional)**
3 mg/kg)
Ripe berries husked and boiled; husks yield highest phenolic concentrations including quercetin 3-O-glucuronide (up to 564.. Used topically or ingested as an infusion in folk medicine for fever and wounds; no validated dosing protocol exists.
**Leaf Poultice (Topical Traditional)**
Fresh or dried leaves crushed and applied directly to wounds in traditional African and South American practice; antimicrobial monoterpenes and tannins provide mechanistic rationale but clinical dose is undefined.
**Standardization Note**
No commercial standardized extracts with defined phytochemical specifications have been reported in the literature; all dosing data derives from experimental research preparations only.
Nutritional Profile
The berries of Schinus molle contribute a complex phytochemical profile rather than significant macronutrient content. Phenolic acids include gallic acid (4.9–252.3 mg/kg varying by plant part) and quinic acid (1,288 µg/g in roots). Flavonoids present in roots include rutin (26 µg/g) and kaempferol (19 µg/g), while husks are enriched in quercetin 3-O-glucuronide (up to 564.3 mg/kg). Gallotannins such as β-glucogallin range from 76.0 to 443.6 mg/kg with the highest concentrations in husks and lowest in seeds. The essential oil fraction constitutes a significant volatile phytochemical pool dominated by α-phellandrene (34–47%), β-myrcene (8–24%), limonene (14%), β-phellandrene (7–21%), α-pinene (4.8%), and α-terpineol (8.38%). Condensed tannins in root extracts measure approximately 114.83 mg catechin equivalents per gram dry weight. Bioavailability of these compounds in human contexts has not been studied; lipophilic monoterpenes are generally expected to be absorbed rapidly via passive diffusion, while polyphenol bioavailability depends heavily on gut microbiome metabolism.
How It Works
Mechanism of Action
Quantum mechanical calculations confirm that α-phellandrene, β-phellandrene, and β-myrcene possess high nucleophilic Fukui indices, enabling them to donate electrons to reactive oxygen species and electrophilic microbial cell components, thereby exerting antioxidant and membrane-disrupting antimicrobial effects. At the cellular level, SM_EO upregulates BCL-2 protein expression in MCF7 human breast cancer cells in a dose-dependent fashion between 16 and 64 µg/mL, suggesting interference with the intrinsic apoptotic pathway, though whether this reflects a pro-survival artifact or a cytostatic mechanism requires further clarification. Gallic acid, quinic acid, and gallotannins in root and husk extracts inhibit free radical propagation through hydrogen atom transfer and single electron transfer mechanisms, consistent with measured DPPH IC50 values near 54.41 µg/mL. Flavonoids such as quercetin 3-O-glucuronide and kaempferol further contribute anti-inflammatory activity through inhibition of NF-κB signaling and suppression of prostaglandin synthesis via COX pathway modulation, providing a plausible molecular basis for traditional antipyretic use.
Clinical Evidence
No human clinical trials for Schinus molle have been identified in the peer-reviewed literature as of the available evidence. All quantitative outcome data originate from in vitro cell culture systems and invertebrate toxicity models, representing the earliest stages of preclinical investigation. Outcomes measured include bacterial growth inhibition (MIC values), free radical scavenging capacity (IC50), cancer cell line proliferation, and nematode survival, none of which directly translate to human therapeutic efficacy or safety. Confidence in clinical benefit remains very low, and the ingredient should be categorized as a research-stage botanical with promising but unvalidated bioactivity.
Safety & Interactions
Schinus molle essential oil exhibited no significant toxicity in Caenorhabditis elegans at concentrations of 0.078–10 mg/mL, and computational ADME-Tox models classify its primary monoterpenes as favorable candidates, but comprehensive human toxicology data including organ-specific effects, maximum tolerated doses, and long-term safety are entirely absent from the published literature. No human clinical adverse event data, drug interaction studies, or contraindication profiles have been formally documented; caution is warranted given the high concentration of reactive monoterpenes in the essential oil, which may cause skin sensitization or mucous membrane irritation at undiluted concentrations. Individuals with known allergies to Anacardiaceae family plants (including mango, cashew, and poison ivy) should exercise caution due to potential cross-reactivity from shared phenolic and resinous constituents. Pregnancy and lactation safety has not been evaluated in any controlled study, and use beyond culinary spice quantities should be avoided in these populations until safety data are available; no established maximum safe supplemental dose exists.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Schinus molle L.Peruvian pepper treeMolle treeCalifornia pepper treePeppercorn treeFalse pepperÁrbol de la vidaMulli (Quechua)
Frequently Asked Questions
What is Schinus molle used for medicinally?
Schinus molle is traditionally used across South America and Africa to treat fever, influenza, wounds, and rheumatic pain, with preparations including bark decoctions, leaf poultices, and berry infusions. These uses are mechanistically supported by in vitro demonstrations of antibacterial activity (MIC 2 µg/mL against B. cereus) and antioxidant capacity (DPPH IC50 54.41 µg/mL), though no human clinical trials have confirmed efficacy in any of these conditions.
What are the active compounds in Schinus molle?
The primary bioactive compounds in Schinus molle are monoterpenes in the seed essential oil, principally α-phellandrene (34–47%), β-myrcene (8–24%), limonene (14%), and β-phellandrene (7–21%), which drive antimicrobial and antioxidant effects. The plant also contains phenolic acids (gallic acid 4.9–252.3 mg/kg, quinic acid 1,288 µg/g in roots), flavonoids (quercetin 3-O-glucuronide up to 564.3 mg/kg in husks, kaempferol 19 µg/g), and gallotannins (β-glucogallin 76–444 mg/kg).
Is Schinus molle safe to use?
Preliminary toxicity testing in Caenorhabditis elegans showed no significant harm at essential oil concentrations of 0.078–10 mg/mL, and computational pharmacokinetic models rate the main monoterpenes as low-risk candidates. However, no human safety studies exist, and individuals with allergies to related Anacardiaceae plants (cashew, mango) should be cautious; undiluted essential oil may cause skin or mucous membrane irritation, and its use during pregnancy or breastfeeding cannot be recommended due to the complete absence of safety data.
Does Schinus molle have anticancer properties?
In vitro studies show that Schinus molle essential oil (SM_EO) modulates BCL-2 protein expression in MCF7 human breast cancer cells in a dose-dependent manner at concentrations of 16–64 µg/mL, suggesting interference with apoptotic regulation. This finding is preliminary and derived solely from cell culture experiments; no animal studies or human clinical trials have evaluated anticancer activity, and it would be premature to attribute cancer-treating properties to this botanical based on current evidence.
What is the correct dosage of Schinus molle extract or essential oil?
No standardized or clinically validated dosage for Schinus molle exists in any form—essential oil, aqueous extract, or dried herb—as the ingredient has not progressed to human clinical trials. Experimental research has used essential oil at MIC concentrations of 2–32.5 µg/mL for antibacterial testing and aqueous root extracts at IC50 values around 54–207 µg/mL for antioxidant assays; traditional folk preparations typically involve 10–30 g of dried root or bark per liter of water as a decoction, but these quantities have not been subject to safety or efficacy evaluation in controlled human studies.
How effective is Schinus molle essential oil against foodborne pathogens compared to conventional preservatives?
Schinus molle essential oil demonstrates potent antimicrobial activity with minimum inhibitory concentrations as low as 2 µg/mL against Bacillus cereus and 32.5 µg/mL against Yersinia enterocolitica and Salmonella species, suggesting comparable or superior efficacy to some conventional food preservatives. The α-phellandrene and β-myrcene components are responsible for this antibacterial potency, making it a promising candidate for natural food safety applications. However, regulatory approval and cost-effectiveness relative to synthetic alternatives remain important practical considerations for commercial food industry adoption.
Does Schinus molle interact with antibiotics or antimicrobial medications?
While Schinus molle possesses intrinsic antimicrobial properties, direct pharmacokinetic interactions with prescription antibiotics have not been extensively documented in clinical literature. Theoretically, concurrent use of Schinus molle with antimicrobial drugs could produce additive or synergistic effects, though clinical significance remains unclear. Individuals taking antibiotics should consult a healthcare provider before supplementing with Schinus molle to avoid potential overlapping mechanisms or unexpected outcomes.
Which part of Schinus molle (fruit, leaf, root, or essential oil) has the strongest antimicrobial and antioxidant activity?
The essential oil fraction, particularly rich in volatile terpenes like α-phellandrene and β-myrcene, demonstrates the most potent antimicrobial activity with the lowest minimum inhibitory concentrations against pathogenic bacteria. Root aqueous extracts show notable antioxidant activity, suggesting that different plant parts offer complementary bioactive profiles. The choice between forms depends on the intended application: essential oil for antimicrobial purposes and aqueous extracts for antioxidant support.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w schinus-molle-peruvian-pepper-tree curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
